Compounding Pharmacy Market - Global Forecast 2026-2032

The compounding pharmacy market is transforming, driven by mounting regulatory standards, a shift toward personalized therapies, and the need for greater supply chain resilience. Organizations are prioritizing rigorous quality systems and technology-enabled traceability to meet evolving clinical and operational expectations.

Market Snapshot: Compounding Pharmacy Market Growth

The compounding pharmacy market grew from USD 16.45 billion in 2025 to USD 17.28 billion in 2026 and is forecast to reach USD 24.35 billion by 2032 at a CAGR of 5.75%. Growth is supported by increasing demand for patient-specific medications, rising emphasis on regulatory compliance, and expansion of both sterile and non-sterile compounding services.

Scope & Segmentation

Service Types: Includes both sterile and non-sterile compounding services designed to address diverse clinical requirements, from inpatient hospital care to ambulatory and specialty settings.
Therapy Areas: Focuses on pain management, hormone replacement therapy, dermatology, and veterinary applications—each requiring tailored operational and quality assurance approaches.
Operational Models: Features insourced and outsourced compounding, centralized pharmacy models, hub-and-spoke distribution, and direct-to-patient delivery, reflecting a range of care and compliance needs.
Technologies: Includes digital master formulation records, workflow automation, gravimetric checks, barcode verification, cleanroom monitoring, and advanced ingredient traceability systems supporting audit readiness.
Regions Covered: Analysis spans the Americas, EMEA, and Asia-Pacific, noting variations in regulatory environment, healthcare infrastructure, and import dependence.
End-User Sectors: Assesses hospitals, retail pharmacies, health systems, and specialty compounding centers, each with distinct workflow and procurement priorities.

Key Takeaways for Decision-Makers

Quality and compliance rigor are now minimum requirements; documented systems, environmental controls, and transparent sourcing drive differentiation and institutional trust.
Clinical demand is evolving from filling supply gaps to supporting true personalization—enabling precision dosing and alternate formulations for populations with unique needs.
Technology adoption increases audit readiness and operational consistency, with automation and digital records reducing human error and supporting compliance mandates.
Supplier qualification and resilient procurement strategies are vital due to global ingredient sourcing volatility, requiring proactive risk management and contingency planning.
Outcomes in specialty niches—such as hormone optimization and dermatology—depend on robust documentation, patient counseling, and ongoing clinical collaboration.
Operational excellence must reflect specific segment needs; sterile and non-sterile environments face different pressures, requiring tailored approaches across settings.

Tariff Impact: 2025 U.S. Tariffs and Sourcing Risks

Recent U.S. tariffs have introduced cost pressures and sourcing complexity, impacting APIs, excipients, and packaging components. This environment amplifies the need for supplier diversification, robust inventory planning, and contract agility. Organizations are responding by reassessing their sourcing strategies, prioritizing alternate geographies, and deploying risk-based supplier scorecards. These measures help mitigate supply disruption and protect both patient care continuity and financial stability.

Primary Keyword in Focus: Compounding Pharmacy Market

The compounding pharmacy market is marked by a transition toward production-like quality expectations within pharmacy environments and expanding technology use. Stakeholders are integrating standardized protocols, audit-ready facilities, and advanced traceability to support both clinical outcomes and compliance.

Methodology & Data Sources

This research is grounded in structured secondary analysis of regulatory and industry trends, complemented by primary interviews with stakeholders across the value chain. Insights were cross-referenced and validated through a triangulated synthesis to ensure accuracy and market relevance.

Why This Report Matters

Enables executives to benchmark quality, compliance, and sourcing practices against leading operators and emerging regulations.
Offers actionable segmentation and technology insights, helping align operational strategy with specific therapy areas and care settings.
Equips procurement and clinical teams to anticipate regulatory shifts, manage input volatility, and ensure sustained patient access.

Conclusion

As the market evolves, leadership teams must balance customization with repeatable quality and supply resilience. Sustainable growth requires disciplined governance, proactive sourcing, and technology-enabled processes that protect patient safety and institutional credibility.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Compounding Pharmacy Market, by Therapeutic Area

8.1. Dermatology
8.2. Hormone Replacement Therapy
8.3. Pain Management
8.4. Pediatrics
8.4.1. Children & Adolescents
8.4.2. Infants & Toddlers
8.4.3. Neonatal
8.5. Veterinary
8.5.1. Large Animal
8.5.2. Small Animal

9. Compounding Pharmacy Market, by Dosage Form

9.1. Injectable
9.1.1. Intramuscular
9.1.2. Intravenous
9.1.3. Subcutaneous
9.2. Ophthalmic
9.2.1. Eye Drops
9.2.2. Ointments
9.3. Oral
9.3.1. Capsules
9.3.2. Suspensions
9.3.3. Syrups
9.4. Topical
9.4.1. Creams & Ointments
9.4.2. Gels & Lotions

10. Compounding Pharmacy Market, by Compounding Type

10.1. Non-Sterile
10.2. Sterile

11. Compounding Pharmacy Market, by Drug Category

11.1. Analgesics
11.1.1. Non-Opioid
11.1.2. Opioid
11.2. Antibiotics
11.2.1. Injectable Antibiotics
11.2.2. Oral Antibiotics
11.2.3. Topical Antibiotics
11.3. Cardiovascular Drugs
11.4. Gastrointestinal Drugs
11.5. Hormones
11.5.1. Estrogen
11.5.2. Progesterone
11.5.3. Testosterone

12. Compounding Pharmacy Market, by End User

12.1. Home Healthcare
12.2. Hospital Pharmacies
12.3. Retail Pharmacies
12.4. Veterinary Clinics

13. Compounding Pharmacy Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Compounding Pharmacy Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Compounding Pharmacy Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Compounding Pharmacy Market
17. China Compounding Pharmacy Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Avella Specialty Pharmacy, LLC
18.6. Bio-Tech Pharmacal, Inc.
18.7. Central Admixture Pharmacy Services, LLC
18.8. Compound Solutions, LLC
18.9. Fagron NV
18.10. Letco Medical, LLC
18.11. Medisca, Inc.
18.12. Nephron Pharmaceuticals Corp
18.13. PharMEDium Services
18.14. Professional Compounding Centers of America, LLC
18.15. Wedgewood Pharmacy, LLC

List of Figures

FIGURE 1. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COMPOUNDING PHARMACY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COMPOUNDING PHARMACY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES COMPOUNDING PHARMACY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA COMPOUNDING PHARMACY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INFANTS & TODDLERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INFANTS & TODDLERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INFANTS & TODDLERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY LARGE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY LARGE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SMALL ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SMALL ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY EYE DROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY EYE DROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SYRUPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CREAMS & OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CREAMS & OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GELS & LOTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GELS & LOTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GELS & LOTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-OPIOID, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-OPIOID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY NON-OPIOID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPIOID, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPIOID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY OPIOID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ORAL ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GASTROINTESTINAL DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GASTROINTESTINAL DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GASTROINTESTINAL DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ESTROGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY ESTROGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PROGESTERONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY PROGESTERONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TESTOSTERONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY TESTOSTERONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 208. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 209. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 210. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 211. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 212. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 213. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 214. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 215. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 216. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 217. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 219. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 220. EUROPE COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 238. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 239. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 240. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 241. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 242. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 243. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 244. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 245. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 246. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 247. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 248. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 249. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 250. AFRICA COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL COMPOUNDING PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 267. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 269. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 270. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 271. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 272. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 273. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 274. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 275. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 276. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 277. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 278. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 279. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 280. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 281. ASEAN COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. GCC COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. GCC COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 284. GCC COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 285. GCC COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 286. GCC COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 287. GCC COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 288. GCC COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 289. GCC COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 290. GCC COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 291. GCC COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 292. GCC COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 293. GCC COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 294. GCC COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 295. GCC COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 296. GCC COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 312. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 313. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 314. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 315. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 316. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 317. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 318. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 319. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 320. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 321. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY COMPOUNDING TYPE, 2018-2032 (USD MILLION)
TABLE 322. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY DRUG CATEGORY, 2018-2032 (USD MILLION)
TABLE 323. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 324. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 325. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
TABLE 326. BRICS COMPOUNDING PHARMACY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 327. G7 COMPOUNDING PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 328. G7 COMPOUNDING PHARMACY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 329. G7 COMPOUNDING PHARMACY MARKET SIZE, BY PEDIATRICS, 2018-2032 (USD MILLION)
TABLE 330. G7 COMPOUNDING PHARMACY MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
TABLE 331. G7 COMPOUNDING PHARMACY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 332. G7 COMPOUNDING PHARMACY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 333. G7 COMPOUNDING PHARMACY MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
TABLE 334. G7 COMPOUNDING PHARMACY MARK

Companies Mentioned

The key companies profiled in this Compounding Pharmacy market report include:

Avella Specialty Pharmacy, LLC
Bio-Tech Pharmacal, Inc.
Central Admixture Pharmacy Services, LLC
Compound Solutions, LLC
Fagron NV
Letco Medical, LLC
Medisca, Inc.
Nephron Pharmaceuticals Corp
PharMEDium Services
Professional Compounding Centers of America, LLC
Wedgewood Pharmacy, LLC

Table Information

Report Attribute	Details
No. of Pages	194
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 17.28 Billion
Forecasted Market Value ( USD ) by 2032	$ 24.35 Billion
Compound Annual Growth Rate	5.7%
Regions Covered	Global
No. of Companies Mentioned	12

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Compounding Pharmacy Market Growth

Scope & Segmentation

Key Takeaways for Decision-Makers

Tariff Impact: 2025 U.S. Tariffs and Sourcing Risks

Primary Keyword in Focus: Compounding Pharmacy Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030

Compounding Pharmacy - Global Strategic Business Report

Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Dosage Form, Patient Group, Therapeutic Area, Sterility, Geographic Coverage and By Company)

Compounding Pharmacies Market - Global Forecast 2026-2032

Sterile Compounding Pharmacies Market Report 2025